PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

CAR-T cells hold memories of past encounters

CU Anschutz scientists find `memory cells’ more effective at killing cancer but they become exhausted faster. Certain proteins may offer a remedy

2025-01-02
(Press-News.org) AURORA, Colo. (Jan. 2, 2025) - Researchers at the University of Colorado Anschutz Medical Campus have discovered that some CAR-T cells engineered to fight cancer and other conditions carry the memory of past encounters with bacteria, viruses and other antigens within them, a finding that may allow scientists to manufacture the cells in more precise and targeted ways.

The study, published today in the journal Nature Immunology, focused on chimeric antigen receptor (CAR)-T cells, an effective therapy against cancer, especially leukemia and lymphoma. T cells, a kind of immune cell, are removed from the patient’s blood, then modified to target cancer and infused back into the patient.

Now researchers have discovered that some of these cells have long, durable memories. They found that even after an extensive manufacturing process to insert the CAR into the cells, CAR-T cells that had past contact with antigens behave differently than those that have never encountered an antigen.

“Unlike most drugs, CAR-T cell products are not uniform. We know that variability exists but the nature of that variability is only beginning to be understood,” said the study’s senior author Terry Fry, MD, professor of pediatrics, oncology and hematology at the University of Colorado School of Medicine and executive director of the Gates Institute at CU Anschutz which manufactures CAR-T cells.  “The thing that was surprising here was the extent to which past interactions with antigens were durably imprinted on the cells.”

Fry and the study’s lead author Kole DeGolier, PhD, an immunology researcher at CU Anschutz, found that `memory cells,’ those with prior antigen experience, killed cancer cells quickly but became exhausted sooner and reproduced slowly, opening the door to a potential relapse. 

At the same time, they discovered favorable disease-fighting capabilities such as robust expansion and resistance to exhaustion of ‘naïve’ cells, those with no antigen experience. A direct comparison of the two cell types allowed the researchers to identify specific gene targets to modulate and improve function. They found that naïve cells specifically could be boosted by targeting genes like RUNX2. The cells also lived longer and reproduced more quickly than memory cells.

“These epigenetic differences can be used to identify genes that can be manipulated to modify function,” DeGolier said.

The study was first done with mouse models, then in human cells. T cells were taken from vaccinated and unvaccinated subjects. The cells from the vaccinated models changed after encountering vaccine antigens in the lymph nodes. They later responded swiftly and effectively against leukemia cells due to the `memory’ of being previously exposed to an antigen.  Yet they exhausted themselves faster than naïve cells.

While naïve T cells lacked the disease-fighting imprinting of memory cells, they became more effective when RUNX2 was added. They also lived longer and the gene protected them against exhaustion, allowing them to keep fighting cancer.

“There was this balance dictated by the prior history of the cell. If you added RUNX2 to a naïve cell you could make it kill cancer a little bit better,” Fry said. “Our studies also generated a large data set of other proteins that we can explore along with RUNX2.”

The findings could lead to more precise engineering of CAR-T cells, allowing them to attack cancer more effectively while potentially alleviating some of the side-effects of the therapy which can include a strong inflammatory response.

“Understanding these differences can guide the development of approaches to rationally manipulate specific cellular attributes,” the authors wrote. “RUNX2 effects in limiting exhaustion programs should also be explored further, especially in solid tumor contexts, where exhaustion plays a large part in limiting anti-tumor T cell responses.”

 

About the University of Colorado Anschutz Medical Campus

The University of Colorado Anschutz Medical Campus is a world-class medical destination at the forefront of transformative science, medicine, education and patient care. The campus encompasses the University of Colorado health professional schools, more than 60 centers and institutes, and two nationally ranked independent hospitals - UCHealth University of Colorado Hospital and Children's Hospital Colorado - that treat more than two million adult and pediatric patients each year. Innovative, interconnected and highly collaborative, the University of Colorado Anschutz Medical Campus delivers life-changing treatments, patient care and professional training and conducts world-renowned research fueled by over $705 million in research grants. For more information, visit www.cuanschutz.edu.

 

 

END


ELSE PRESS RELEASES FROM THIS DATE:

Quantity over quality? Different bees are attracted to different floral traits

2025-01-02
UNIVERSITY PARK, Pa. — When it comes to deciding where they’re going to get their next meal, different species of bees may be attracted to different flower traits, according to a study led by researchers at Penn State and published in PNAS Nexus. The study focused on two species of solitary bees: the horned-face bee, which helps pollinate crops like apples and blueberries, and the alfalfa leafcutting bee, which pollinates alfalfa. The researchers found that the horned-face bees tended to prefer plants with a large number of flowers — for them, quantity was most important. ...

Cancer-preventing topical immunotherapy trains the immune system to fight precancers

2025-01-02
A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is the first to activate specific components of the adaptive immune system, particularly CD4+ T helper cells, which are not known to be involved in traditional cancer treatments. This work highlights the potential for similar immunotherapies to prevent other cancers throughout the body. Results are published in the Journal of Clinical Investigation.  “One of the unique challenges with squamous cell carcinoma is that individuals who develop it are at an increased risk of developing multiple new ...

Blood test can predict how long vaccine immunity will last, Stanford Medicine-led study shows

2025-01-02
When children receive their second measles-mumps-rubella vaccine, around the time they start kindergarten, they gain protection against all three viruses for all or most of their lives. Yet the effectiveness of an influenza vaccine given in October starts to wane by the following spring. Scientists have long been stymied by why some vaccines can coax the body to produce antibodies for decades, while others last mere months. Now, a study led by researchers at Stanford Medicine has shown that variation in vaccine durability can, in part, be pinned on a surprising type ...

The nose knows: Nasal swab detects asthma type in kids

The nose knows: Nasal swab detects asthma type in kids
2025-01-02
Researchers at the University of Pittsburgh have developed a nasal swab test for kids that diagnoses specific asthma subtype, or endotype. This non-invasive approach could help clinicians prescribe medications more precisely and pave the way for research toward better treatments for lesser-studied asthma types, which have been difficult to diagnose accurately until now. Published today in JAMA, the findings are based on data from three independent U.S.-based studies that focused on Puerto Rican and African American youths, who have higher rates of asthma and are more likely to die from the disease than their non-Hispanic white counterparts. “Asthma ...

Knowledge and worry following review of standard vs patient-centered pathology reports

2025-01-02
About The Study: Most study participants could not extract basic information—including whether they have cancer—from standard prostate cancer pathology reports but were able to understand this diagnostic information from the patient-centered pathology reports (PCPRs). Also, they discriminated between risk levels (i.e., lower levels of perceived worry in the low-risk condition) with PCPRs compared with standard reports. Hospital systems should consider including PCPRs with standard pathology reports to improve patient understanding.  Corresponding ...

Cardiovascular disease and breast cancer stage at diagnosis

2025-01-02
About The Study: This case-control study found that individuals with more advanced breast cancer at diagnosis were more likely to have prevalent cardiovascular disease. This finding may be specific to hormone receptor–positive and ERBB2-negative (formerly HER2) disease. Future studies are needed to confirm these findings and investigate interventions to improve patient outcomes, including personalized cancer screening. Corresponding Author: To contact the corresponding author, Kevin T. Nead, MD, MPhil, email ktnead@mdanderson.org. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2024.52890) Editor’s ...

Herpes virus might drive Alzheimer's pathology, study suggests

Herpes virus might drive Alzheimers pathology, study suggests
2025-01-02
PITTSBURGH, Jan. 2, 2025 – University of Pittsburgh researchers uncovered a surprising link between Alzheimer’s disease and herpes simplex virus-1 (HSV-1), suggesting that viral infections may play a role in the disease. The study results are published today in Cell Reports. The study also revealed how tau protein, often viewed as harmful in Alzheimer’s, might initially protect the brain from the virus but contribute to brain damage later. These findings could lead to new treatments targeting infections and the brain’s immune response. “Our study challenges ...

Patients with heart disease may be at increased risk for advanced breast cancer

Patients with heart disease may be at increased risk for advanced breast cancer
2025-01-02
HOUSTON ― Cardiovascular disease (CVD) and cancer are the two leading causes of death in the U.S. According to researchers from The University of Texas MD Anderson Cancer Center, patients diagnosed with late-stage or metastatic breast cancer have a statistically significant increased risk of pre-diagnosis CVD compared to those with early-stage cancer at diagnosis. The study, published today in JAMA Network Open, found those with advanced breast cancer at diagnosis were 10% more likely to have had pre-existing ...

Chinese Medical Journal study reveals potential use of artificial intelligence (AI) in finding new glaucoma drugs

Chinese Medical Journal study reveals potential use of artificial intelligence (AI) in finding new glaucoma drugs
2025-01-02
Glaucoma is a progressive eye disorder characterized by fluid buildup inside the eye, causing ocular hypertension. By 2040, it is estimated that 111.8 million people worldwide will be affected by glaucoma, potentially leading to blindness if left untreated. Currently, there are treatments available to manage ocular hypertension, but a cure for glaucoma remains elusive. Retinal ganglion cells (RGCs) are crucial for transmitting visual signals from the eyes to the brain, and their degeneration leads to optic nerve damage, which is a hallmark of glaucoma.  In recent years, scientists ...

Genomic analysis of modern maize inbred lines reveals diversity and selective breeding effects

Genomic analysis of modern maize inbred lines reveals diversity and selective breeding effects
2025-01-02
Maize is a globally cultivated staple crop and one of the most successful examples of heterosis utilization in food production. The development of elite inbred lines is critical for breeding hybrid varieties and achieving sustained yield improvements. However, efficient breeding of inbred lines faces significant challenges, including the broad origins of germplasm resources, complex and diverse genetic structures, and low accuracy in phenotypic prediction. Advances in modern genomics and artificial intelligence technologies ...

LAST 30 PRESS RELEASES:

Being physically active, even just a couple of days a week, may be key to better health

High-fat diet promote breast cancer metastasis in animal models

A router for photons

Nurses and AI collaborate to save lives, reduce hospital stays

Multi-resistance in bacteria predicted by AI model

Tinker Tots: A citizen science project to explore ethical dilemmas in embryo selection

Sensing sickness

Cost to build multifamily housing in California more than twice as high as in Texas

Program takes aim at drinking, unsafe sex, and sexual assault on college campuses

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

[Press-News.org] CAR-T cells hold memories of past encounters
CU Anschutz scientists find `memory cells’ more effective at killing cancer but they become exhausted faster. Certain proteins may offer a remedy